Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Posttransplantationsdiabetes. Metaboliske konsekvenser af immunsuppression efter organtransplantation
Engelsk titel: Posttransplant diabetes. Metabolic consequences of posttransplant immunosuppressive treatment Läs online Författare: Christiansen E Språk: Dan Antal referenser: 10 Dokumenttyp: Översikt UI-nummer: 07061838

Tidskrift

Ugeskrift for Laeger 2007;169(24)2309-11 ISSN 0041-5782 E-ISSN 1603-6824 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

Posttransplant diabetes (PTDM) is persistent hyperglycemia following organ transplantation and is a serious and frequent complication. PTDM increases the risk of graft failure and cardiovascular disease. The most importance factor is the posttransplant immunosuppressive treatment. PTDM develops when insulin resistance is not compensated by secretory hyperinsulinemia. New immunosuppressive regimes seem promising in reducing PTDM. Guidelines recommend pre- transplantation OGTT, early diagnose of PTDM and individualized immunosuppressive treatment. Antidiabetic treatment should be initiated early.